Skip to contentSkip to footer
      employer cover photo

      PYC Therapeutics

      Is this your company?

      PYC Therapeutics reviews

      A sinking ship - Team Member PYC Therapeutics Employee Review

      1.0
      8 Oct 2025
      Team member
      Recommend
      CEO approval
      Business outlook

      Pros

      If you're a sycophant you'll go far

      Cons

      The company has no HR and a toxic overwork culture and it's eroding the talent density. High turnover and some of the best scientists leaving resulting in a constant exhausting hiring cycle. Also, when you realise your glassdoor rating is so low you internally request positive reviews and management end up writing their own (March) that's not just a red flag, the flag factory is on fire. How embarrassing.

      Explore other reviews about PYC Therapeutics

      2.0
      15 June 2026
      Senior scientist
      Recommend
      CEO approval
      Business outlook

      Pros

      Previously had expert CSO for informative drug design.

      Cons

      Toxic positivity, unrealistic milestones that constantly set the company in a rhythym of racing 3 steps forward and 5 steps back. Chronic burnout experienced by benchside scientists, which contributed to the high turnover and subsequent brain-drain.

      1
      5.0
      4 May 2026
      Anonymous employee
      Recommend
      CEO approval
      Business outlook

      Pros

      Great Company to work for. If you work hard and show your dedication the company returns it ten fold

      Cons

      The perks are great—until they create an entitled mindset. Plenty of ex-staff were more than happy to take everything on offer, but the moment they’re let go, it’s suddenly all the company’s fault. No self-awareness, just blame and complaints

      See reviews by: Helpful|Rating|Date|All
      Related searches: PYC Therapeutics jobs | PYC Therapeutics salaries | PYC Therapeutics benefits | PYC Therapeutics interviews
      PYC Therapeutics reviewsPYC Therapeutics Team Member reviewsPYC Therapeutics review